Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism RANK inhibitors(TNF receptor superfamily member 11a inhibitors), RANKL inhibitors(Tumor necrosis factor ligand superfamily member 11 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metabolic Diseases | Discovery | - | 03 Feb 2026 | |
| Metabolic Diseases | Discovery | - | 03 Feb 2026 | |
| Skin and Musculoskeletal Diseases | Discovery | - | 03 Feb 2026 | |
| Skin and Musculoskeletal Diseases | Discovery | - | 03 Feb 2026 |





